Position in INVA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,853,340
+$53,951 QoQ
Shares Held
81,609
+5.7% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#81
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JAMES INVESTMENT RESEARCH, INC. holds $7,400,403 across 7 Biotechnology names. INVA ranks #2 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
26,578 | $2,080,260 | |
| 2 | INVA |
Innoviva, Inc.
This page
|
81,609 | $1,853,340 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
17,122 | $1,488,757 | |
| 4 | 43,686 | $1,373,050 | |||
| 5 | ZYME |
Zymeworks Inc.
|
10,925 | $285,579 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
14,833 | $252,161 | |
| 7 | IRD |
Opus Genetics, Inc.
|
16,364 | $67,256 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,853,340 | 81,609 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,799,389 | 77,227 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,542,368 | 77,157 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,408,115 | 77,157 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,312,781 | 65,345 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,184,704 | 65,345 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,133,735 | 65,345 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,261,869 | 65,348 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,071,707 | 65,348 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $865,814 | 56,812 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,232,064 | 76,812 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $997,787 | 76,812 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $977,816 | 76,812 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $864,135 | 76,812 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $1,056,290 | 79,720 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $780,679 | 67,242 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,319,972 | 89,429 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,558,313 | 80,533 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $1,387,624 | 80,442 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,177,085 | 70,442 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $944,627 | 70,442 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $730,527 | 61,132 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $1,012,634 | 81,730 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,079,390 | 103,291 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $1,777,458 | 127,143 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $1,389,914 | 118,190 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||